Results for tag: "Gut Microbiota"

The Gut Microbiota market is a subset of the Gastroenterology market, focusing on the study of the bacteria, fungi, and other microorganisms that live in the human digestive tract. It is a rapidly growing field of research, with a focus on understanding the role of the gut microbiota in health and disease. Research has shown that the gut microbiota plays a role in a variety of conditions, including obesity, diabetes, inflammatory bowel disease, and colorectal cancer. The Gut Microbiota market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of new technologies for studying the gut microbiota. Companies in the market include uBiome, Second Genome, and Seres Therapeutics. Show Less Read more